(RVNC)—I mentioned Daewoong’s botulinum toxin on this board in 2016 (#msg-121755626). I was initially skeptical that Daewoong’s US partner, Alphaeon/Evolus, would submit a BLA, but they recently did so now we’ll get to see what the FDA thinks about Daewoong’s manufacturing facilities in Korea.
Botulinum toxin in bulk form is dangerous stuff! I have an inkling the FDA will regard RVNC’s all-US supply chain as comforting, unless a major earthquake hits Silicon Valley, LOL.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”